Finally, Musashi-1 has been identified as a potential therapeutic target in other malignancies, including breast cancer [15] and glioblastoma [68] and here, we report an in-depth evaluation of its targeting in endometrial cancer. This evidence concerns the gene MSI1 and breast cancer.